| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 09/20/2001 | WO2001068851A2 Polypeptides and nucleic acids encoding same |
| 09/20/2001 | WO2001068848A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/20/2001 | WO2001068837A2 Antisense oligonucleotides of the human chk1 gene and uses thereof |
| 09/20/2001 | WO2001068836A2 Methods and compositions for rna interference |
| 09/20/2001 | WO2001068834A1 Nucleotide detector, process for producing the same and process for forming fine particle membrane |
| 09/20/2001 | WO2001068833A2 Recombinant hhv8 dna |
| 09/20/2001 | WO2001068825A1 Human nim1 kinase |
| 09/20/2001 | WO2001068819A1 Improved methods to isolate, identify, quantify, and propagate chicken infectious anemia virus and high titer vaccine |
| 09/20/2001 | WO2001068818A2 Hcv ns2/3 fragments and uses thereof |
| 09/20/2001 | WO2001068805A2 Human olfactory receptors and genes encoding same |
| 09/20/2001 | WO2001068804A2 Nucleic acid sequences associated with aging, particularly skin aging |
| 09/20/2001 | WO2001068706A1 Melanin concentrating hormone receptor chimeric and fusion proteins |
| 09/20/2001 | WO2001068705A2 Il-17 receptor like molecules and uses thereof |
| 09/20/2001 | WO2001068704A2 G-protein coupled receptors |
| 09/20/2001 | WO2001068696A1 Human immune response proteins |
| 09/20/2001 | WO2001068671A1 Method of making protein arrays |
| 09/20/2001 | WO2001068670A2 Family of mechanically sensitive human potassium channels activated by polyunsaturated fatty acids and use thereof |
| 09/20/2001 | WO2001068668A1 Atm mutations in breast cancer |
| 09/20/2001 | WO2001068664A2 Mass labels |
| 09/20/2001 | WO2001068120A2 Uses of bombesin receptor 3 |
| 09/20/2001 | WO2001067855A2 Transgenic mice containing targeted gene disruptions |
| 09/20/2001 | WO2001049745A9 Methods and compositions for determining the purity of chemically synthesized nucleic acids |
| 09/20/2001 | WO2001030973A3 Genetic sequences associated with neural cell proliferation and disease |
| 09/20/2001 | WO2001029248A3 Method for amplifying and detecting nucleic acid |
| 09/20/2001 | WO2001029070A8 Modulation of t cell differentiation for the treatment of t helper cell mediated diseases |
| 09/20/2001 | WO2001028579A3 Inhibitors of proteasomal activity for stimulating bone and hair growth |
| 09/20/2001 | WO2001023612A3 Determining mutations by selective reaction of the 2'-ribose position in hybridized oligonucleotides |
| 09/20/2001 | WO2001020018A8 Diagnosing and treating arthritic disorders |
| 09/20/2001 | WO2001018051A3 Mammalian interleukin-12 p40 and interleukin b30, combinations thereof, antibodies, uses in pharmaceutical compositions |
| 09/20/2001 | WO2001016358A3 Method of screening for triacyglycerol hydrolase inhibitors |
| 09/20/2001 | WO2001016317A3 Polycyclic aromatic hydrocarbon induced molecules |
| 09/20/2001 | WO2001016165A3 Apoptin-associating protein |
| 09/20/2001 | WO2001014593A3 A method for producing quality assured biological sample and composition containing the same |
| 09/20/2001 | WO2001014581A3 Hdac4 and hdac5 in the regulation of cardiac gene expression |
| 09/20/2001 | WO2001013944A3 Stress-proteins from extra-cellular pathogens as vaccines against infectious agents |
| 09/20/2001 | WO2001011078A8 Amplification method for detection of target nucleic acids involving fluorescence energy transfer |
| 09/20/2001 | WO2001011077A9 Methods of diagnosing or treating irritable bowel syndrome and other disorders |
| 09/20/2001 | WO2001011006A3 Detection of micro-organisms |
| 09/20/2001 | WO2001010456A3 Peptides that block viral infectivity and methods of use thereof |
| 09/20/2001 | WO2001000820A3 METHODS AND COMPOSITIONS FOR PRODUCING 5' ENRICHED cDNA LIBRARIES |
| 09/20/2001 | WO2000065092A9 Blocking non-specific binding of granulocytes in microorganism detection |
| 09/20/2001 | WO2000046246A8 Alpha-2-macroglobulin therapies and drug screening methods for alzheimer's disease |
| 09/20/2001 | WO2000044774A9 Inhibition of stat3 signal transduction for human cancer therapy |
| 09/20/2001 | WO2000040757A9 Method of identifying nucleic acids |
| 09/20/2001 | WO2000037490A3 Outer surface proteins, their genes, and their use |
| 09/20/2001 | WO2000018899A3 Angiotensin converting enzyme homolog and its use |
| 09/20/2001 | WO1999040102A9 Novel molecules of the card-related protein family and uses thereof |
| 09/20/2001 | US20010023500 Leukotriene B4 receptor transgenic mice |
| 09/20/2001 | US20010023290 Process for separation of polynucleotide fragments |
| 09/20/2001 | US20010023066 Methods of screening for or treating cancers or autoimmune disorders in which a complement C3 or C3 related protein is associated |
| 09/20/2001 | US20010023065 Polymerase chain reaction |
| 09/20/2001 | US20010023062 Screening receptors |
| 09/20/2001 | US20010023061 Assaying the effect of test tumor cell modulation |
| 09/20/2001 | US20010022971 IBD-associated microbial nucleic acid molecules |
| 09/20/2001 | EP1144615A3 METHODS AND COMPOSITIONS FOR PRODUCING 5' ENRICHED cDNA LIBRARIES |
| 09/20/2001 | DE19963198A1 Diagnosing neurodegenerative disease, e.g., Creutzfeld-Jakob disease and Bovine Spongiform Encephalopathy, on formalin-fixed tissue sections comprises spreading and cleaning a tissue sample on membrane for incubation with protease solution |
| 09/20/2001 | DE10013618A1 New polypeptides from Drosophila melanogaster have biological activity of peptide receptor, useful to find new compounds for plant protection and insecticides |
| 09/20/2001 | DE10013580A1 Rezeptor für Latrotoxin aus Insekten Receptor for Latrotoxin from insects |
| 09/20/2001 | DE10013225A1 Purifying, stabilizing and isolating nucleic acids from samples, particularly feces, useful for diagnosis, by homogenizing with buffer, in absence of carbohydrate-based adsorbent |
| 09/20/2001 | DE10012220A1 Test system comprising cells expressing different cytochrome P450 2D6 alleles used to investigate genetically caused metabolite toxicity and to determine toxic, mutagenic or carcinogenic effect of compounds |
| 09/20/2001 | DE10011480A1 Nucleic acid for amplifying and quantitatively and qualitatively detecting aquaporin genes, gene fragments, RNA or expression of an aquaporin gene from Vitis species |
| 09/20/2001 | DE10009467A1 Enzymatic electrochemical measuring device, for determining glucose in urine, comprises a sensor based on a pair of Clark electrodes, where only one contains an enzyme |
| 09/20/2001 | CA2674427A1 A method of sorting cells |
| 09/20/2001 | CA2531917A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/20/2001 | CA2406878A1 Implantable analyte sensor |
| 09/20/2001 | CA2406814A1 Implantable analyte sensor |
| 09/20/2001 | CA2406672A1 Atm mutations in breast cancer |
| 09/20/2001 | CA2403696A1 Use of genetic markers to diagnose familial dysautonomia |
| 09/20/2001 | CA2403405A1 Hcv ns2/3 fragments and uses thereof |
| 09/20/2001 | CA2403397A1 Methods and compositions for rna interference |
| 09/20/2001 | CA2403373A1 A lysosomal pepstatin-insensitive proteinase as a novel biomarker for detecting and diagnosing breast cancer |
| 09/20/2001 | CA2403222A1 Mitochondrial dosimeter |
| 09/20/2001 | CA2403201A1 Family of mechanically sensitive human potassium channels activated by polyunsaturated fatty acids and use thereof |
| 09/20/2001 | CA2403118A1 Nucleic acid primers of acid-fast bacterium and method of identifying acid-fast bacterium |
| 09/20/2001 | CA2402940A1 G-protein coupled receptors |
| 09/20/2001 | CA2402912A1 Transgenic mice containing targeted gene disruptions |
| 09/20/2001 | CA2402908A1 Assay for agents that induce chemokinesis |
| 09/20/2001 | CA2402877A1 Ifi206, a novel interferon-induced polypeptide, and nucleic acids encoding the same |
| 09/20/2001 | CA2402772A1 Apolipoprotein-a-i regulation of t-cell signalling |
| 09/20/2001 | CA2402729A1 Human immune response proteins |
| 09/20/2001 | CA2402665A1 Compositions and methods for simultaneous detection of multiple biological entities |
| 09/20/2001 | CA2402483A1 Methods for detection of differences in nucleic acids |
| 09/20/2001 | CA2402424A1 Methods of making and using microarrays of anti-ligands for the analysis of protein expression in cells |
| 09/20/2001 | CA2402248A1 Polypeptides and nucleic acids encoding same |
| 09/20/2001 | CA2402237A1 Improved methods to isolate, identify, quantify, and propagate chicken infectious anemia virus and high titer vaccine |
| 09/20/2001 | CA2402233A1 Methods of detecting cancer using cellular autofluorescence |
| 09/20/2001 | CA2402189A1 Methods and apparatus for the location and concentration of polar analytes using an alternating electric field |
| 09/20/2001 | CA2402147A1 Melanin concentrating hormone receptor chimeric and fusion proteins |
| 09/20/2001 | CA2402041A1 Antisense oligonucleotides of the human chk1 gene and uses thereof |
| 09/20/2001 | CA2401448A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/20/2001 | CA2401417A1 High fidelity reverse transcriptases and uses thereof |
| 09/20/2001 | CA2401406A1 Human olfactory receptors and genes encoding same |
| 09/20/2001 | CA2401273A1 Il-17 receptor like molecules and uses thereof |
| 09/20/2001 | CA2401270A1 Method for labeling individual cells |
| 09/20/2001 | CA2400238A1 Human nim1 kinase |
| 09/20/2001 | CA2399112A1 Molecular weight markers for western blot |
| 09/20/2001 | CA2374155A1 A detection method of protein-protein interaction |
| 09/19/2001 | EP1134687A2 Method for displaying results of hybridization experiments |
| 09/19/2001 | EP1134294A2 Method for producing immobilized nucleic acid strand |
| 09/19/2001 | EP1134293A2 Comparative genomic hybridization (CGH) |